HSPH Commencement 2010
June 14 2010 - The Immaculata De Vivo laboratory would like to congratulate Dr. Stalo Karageorgi in earning her Doctor of Science degree in Environmental Health and Epidemiology. After successfully defending her thesis on "Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study", Stalo received her diploma in a lavish commencement ceremony befitting of the most outstanding Harvard graduates.
Prof. Peter Kraft, Prof. Immaculata De Vivo, and the newly minted Dr. Stalo Karageorgi.
Dichloroacetate featured in Cancer Monthly
July 11 2008-Our research on Dichloroacetate is currently featured in this month's edition of Cancer Monthly. The article can be found HERE. A special thank you to Stephanie Watson for the outstanding article.
Telomere Real Time PCR Assay
March 9 2008 - The De Vivo Laboratory is extensively performing assays for the determination of relative telomere length in epidemiological studies. We use a high-throughput 384-well format on an ABI 7900HT platform. We have successfully completed projects for numerous researchers thoughout the country including those at the Harvard School of Public Health and National Cancer Institute.
Manuscripts from several projects and collaborations have been published while numerous others are in preparation. These include:
Telomere Length, Cigarette Smoking, and Bladder Cancer Risk in Men and Women
Telomere Length and Parkinson's Disease Risk
Shorter Telomeres May Mark Early Risk of Dementia
For more information, please contact Dr. Immaculata De Vivo.
Dichloroacetate: A novel cancer therapeutic agent
March 8 2008 - Our latest manuscript, "Dichloroacetate Induces Apoptosis in Endometrial Cancer Cells" was recently accepted in the journal 'Gynecologic Oncology'. Dichloroacetate is a novel and potentially exciting cancer therapeutic agent which attacks aerobic glycolysis common to most cancers.